Atreca Inc. (NASDAQ: BCEL) stock closed at 0.2197 per share at the end of the most recent trading day (a 2.19% change compared to the prior day closing price) with a volume of 789.81K shares and market capitalization of 8.71M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 128 people. Atreca Inc. CEO is John A. Orwin.

The one-year performance of Atreca Inc. stock is -79.91%, while year-to-date (YTD) performance is -72.56%. BCEL stock has a five-year performance of %. Its 52-week range is between 0.1902 and 2.05, which gives BCEL stock a 52-week price range ratio of 1.59%

Atreca Inc. currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 0.43, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -58.73%, a ROC of -52.75% and a ROE of -86.03%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Atreca Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.36 for the next earnings report. Atreca Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Atreca Inc. is Moderate Buy (2.14), with a target price of $12.29, which is +5 493.99% compared to the current price. The earnings rating for Atreca Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Atreca Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Atreca Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.87, ATR14 : 0.04, CCI20 : -12.38, Chaikin Money Flow : -0.34, MACD : -0.01, Money Flow Index : 41.84, ROC : -8.46, RSI : 46.02, STOCH (14,3) : 36.97, STOCH RSI : 0.91, UO : 25.42, Williams %R : -63.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Atreca Inc. in the last 12-months were: Phillips Courtney (Sold 4 076 shares of value $3 872 ), Serafini Tito (Sold 5 487 shares of value $5 213 )